Dysregulated ceRNA network modulated by copy number variation‐driven lncRNAs in breast cancer: A comprehensive analysis. (10th January 2023)
- Record Type:
- Journal Article
- Title:
- Dysregulated ceRNA network modulated by copy number variation‐driven lncRNAs in breast cancer: A comprehensive analysis. (10th January 2023)
- Main Title:
- Dysregulated ceRNA network modulated by copy number variation‐driven lncRNAs in breast cancer: A comprehensive analysis
- Authors:
- Zhu, Xiaotao
Song, Jialu
Wang, Mingzheng
Wang, Xiaohui
Lv, Lin - Abstract:
- Abstract: Breast cancer is a malignancy harmful to physical and mental health in women, with quite high mortality. Copy number variations (CNVs) are vital factors affecting the progression of breast cancer. Detecting CNVs in breast cancer to predict the prognosis of patients has become a promising approach to accurate treatment in recent years. The differential analysis was performed on CNVs of long noncoding RNAs (lncRNAs) as well as the expression of lncRNAs, microRNAs (miRNAs) and mRNAs in normal tissue and breast tumor tissue based on The Cancer Genome Atlas (TCGA) database. The CNV‐driven lncRNAs were identified by the Kruskal–Wallis test. Meanwhile, a competitive endogenous RNA (ceRNA) network regulated by CNV‐driven lncRNA was constructed. As the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed, the mRNAs in the dysregulated ceRNA network were mainly enriched in the biological functions and signaling pathways, including the Focal Adhesion‐PI3K‐Akt–mTOR‐signaling pathway, the neuronal system, metapathway biotransformation Phase I and II and blood circulation, etc. The relationship between the CNVs of five lncRNAs and their gene expression in the ceRNA network was analyzed via a chi‐square test, which confirmed that except for LINC00243, the expression of four lncRNAs was notably correlated with the CNVs. The survival analysis revealed that only the copy number gain of LINC00536 was evidently related to the poor prognosis ofAbstract: Breast cancer is a malignancy harmful to physical and mental health in women, with quite high mortality. Copy number variations (CNVs) are vital factors affecting the progression of breast cancer. Detecting CNVs in breast cancer to predict the prognosis of patients has become a promising approach to accurate treatment in recent years. The differential analysis was performed on CNVs of long noncoding RNAs (lncRNAs) as well as the expression of lncRNAs, microRNAs (miRNAs) and mRNAs in normal tissue and breast tumor tissue based on The Cancer Genome Atlas (TCGA) database. The CNV‐driven lncRNAs were identified by the Kruskal–Wallis test. Meanwhile, a competitive endogenous RNA (ceRNA) network regulated by CNV‐driven lncRNA was constructed. As the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed, the mRNAs in the dysregulated ceRNA network were mainly enriched in the biological functions and signaling pathways, including the Focal Adhesion‐PI3K‐Akt–mTOR‐signaling pathway, the neuronal system, metapathway biotransformation Phase I and II and blood circulation, etc. The relationship between the CNVs of five lncRNAs and their gene expression in the ceRNA network was analyzed via a chi‐square test, which confirmed that except for LINC00243, the expression of four lncRNAs was notably correlated with the CNVs. The survival analysis revealed that only the copy number gain of LINC00536 was evidently related to the poor prognosis of patients. The CIBERSORT algorithm showed that five lncRNAs were correlated with the abundance of immune cell infiltration and immune checkpoints. In a word, by analyzing CNV‐driven lncRNAs and the ceRNA network regulated by these lncRNAs, this study explored the mechanism of breast cancer and provided novel insights into new biomarkers. Abstract : In this study, CNV‐driven lncRNAs and the ceRNA network regulated by these lncRNAs were finally obtained based on TCGA database and bioinformatics analysis. Chi‐square test and K‐M curves were used to analyze the relationship between the expression of these lncRNAs and CNV status and the prognosis of patients, and the correlation between these lncRNAs and immunity was also analyzed. … (more)
- Is Part Of:
- Journal of gene medicine. Volume 25:Number 3(2023)
- Journal:
- Journal of gene medicine
- Issue:
- Volume 25:Number 3(2023)
- Issue Display:
- Volume 25, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 25
- Issue:
- 3
- Issue Sort Value:
- 2023-0025-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2023-01-10
- Subjects:
- breast cancer -- ceRNA network -- copy number variation -- lncRNA -- prognosis
Genetic transformation -- Periodicals
Gene Transfer -- Periodicals
Gene Therapy -- Periodicals
616.042 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/jgm.3471 ↗
- Languages:
- English
- ISSNs:
- 1099-498X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.668000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26100.xml